Featured Topics |
|
|
 |
|
News |
|
|
GSK Announces Plans to Share Clinical Trial Data
In its commitment to transparency, GlaxoSmithKline (GSK) has outlined plans to share detailed data from its clinical trials. GSK is to establish a new online system that will enable researchers to request access to anonymised patient level data. More... |
|
|
Takeda to Acquire Inviragen for up to $250 Million
Takeda and US vaccines maker Inviragen jointly announced that they have entered into a definitive agreement for Takeda to acquire Inviragen for an upfront payment of $35 million and future payments of up to $215 million upon achievement of key commercial milestones, linked to the progress of clinical development. More... |
|
Industry Briefs |
|
|
|
|
|
Agilent |
Support and Solutions from Agilent for Impurity Profiling: New Genotoxic Impurities Primer
Agilent partners with Pharma for great results. Download or request a hard copy of our new guide, Genotoxic Impurities in Pharmaceutical Products: Regulations and Analysis, authored by Ludwig Huber. The guide provides specific guidelines for genotoxic impurities and recommendations for implementation according to EMA and FDA guidelines.
Get your copy now |
|
|
Shimadzu |
Nexera X2 – X-ceptional insights
Ultra-high sensitivity, expanded flexibility, increased stability and robustness - the new Nexera X2 UHPLC system targets routine analysis and applications in highly regulated environments demanding complex system setups. Read more
|
|
|
NIBRT |
National Institute for Bioprocessing Research and Training (NIBRT)
Advanced biopharmaceutical training in the most cutting-edge analytical methods and techniques: NIBRT's state-of-the-art facility in Dublin, Ireland provides comprehensive, innovative training solutions for academia and industry. Read more
|
|
|
Rigaku |
Avoid the 483–Unconventional Approaches to Elevate Your Quality Program
Live Webcast: Thursday, May 23, 2013 at 8:00am PDT/ 11:00am EDT
Register Free at www.spectroscopyonline.com/ramananalysis
|
|
|
|
|
 |
|
Webinar: Good Corporate Citizenship and the Respect for Copyright in Life Sciences |
In the digital age, your employees share scientific research whenever and wherever they want. But did they ask the rightsholder for permission? Could routine information exchanges in the course of R&D collaboration place your organization at risk? Learn why respecting the copyright of others is the right thing to do for research-driven pharmaceutical companies and increasingly reflects good corporate citizenship.
Join us for a COMPLIMENTARY WEBINAR |
 |
China’s leading international pharmaceutical ingredient event |
CPhI China brings the pharmaceutical ingredients market together with co-located events, including pharma machinery (P-MEC), packaging (InnoPack), biopharmaceuticals (BioPh), laboratory equipment (LabWorld) and contract services (ICSE) under one roof.
With more than 1,900 exhibiting companies and 30,000 attendees, CPhI China is the place to meet current partners, find new suppliers, check out, evaluate thousands of pharma products and vendors at one place, and learn about the latest industry trends. www.cphi-china.com |
 |
|
|
|
|
 |
|
This week we would like to know...
What has been the most significant benefit of applying quality-by-design (QbD) principles?

|
|
|
Reference Library |
Pharmaceutical Technology presents its Process Analytical Technology resource guide combo
A compilation of informative, useful articles designed to help you meet the challenges of process analytical technology, become more efficient in testing, reduce over-processing, enhance consistency, and minimize rejects ... Click here
|
|
Contact Us |
Click here to contact editorial.
Click here to contact sales. |
|